Mitotix Incorporated Company Profile

22:01 EST 17th November 2017 | BioPortfolio

Mitotix is a privately held company focused on the discovery and development of therapeutic products for the treatment of diseases resulting from inappropriate cell proliferation. The Company's approach is based on Mitotix's unique understanding of the mechanisms that regulate the cell division cycle, the process by which cells grow, each replicating into two daughter cells. The Company's initial therapeutic programs have the potential to yield new treatments for cancer, major opportunistic infections, immune disorders, certain cardiovascular diseases and inflammatory disorders.

The Company's technology builds on the recent, dramatic advances in understanding the regulatory molecules that control the events of the cell division cycle. Collectively, these advances define a highly promising class of new protein (enzyme) targets, which offer the potential to develop specific drugs for the treatment of cell proliferation diseases.

Drugs emanating from Mitotix's discovery and development programs may define a new therapeutic paradigm by allowing the treatment of cancers based on their underlying molecular defects (e.g. mutations in the cell cycle regulatory genes) rather than on tumor types identified by location (breast, lung, colon, etc.). Moreover, this technology may allow for the development of potential drugs for other cell proliferation disorders based on new mechanisms of action.


One Kendall Square
United States of America


Phone: 617 225 0001
Fax: 617 225 0005

News Articles [1 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [38 Associated Companies listed on BioPortfolio]


Mitotix Incorporated

Mitotix is a privately held company focused on the discovery and development of therapeutic products for the treatment of diseases resulting from inappropriate cell proliferation. The Company's approa...


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...


Founded in 2008 by the Axis Biotec Brasil™ group (, PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....


COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

More Information about "Mitotix Incorporated" on BioPortfolio

We have published hundreds of Mitotix Incorporated news stories on BioPortfolio along with dozens of Mitotix Incorporated Clinical Trials and PubMed Articles about Mitotix Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mitotix Incorporated Companies in our database. You can also find out about relevant Mitotix Incorporated Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record